Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Working Life: Jane Griffiths

June 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Working Life, brett wells, jane griffiths

After completing her PhD in Biochemistry at the University of Aberystwyth in 1982, Jane worked her way up the Johnson …
Feature

FDA approves Roche’s breast cancer drug

June 11, 2012 Sales and Marketing EMA, FDA, Perjeta, Roche, breast cancer

US regulators have approved Roche’s new breast cancer drug after granting it a priority review to speed up the process. …
News

BMS invests $15 million in Asian diabetes programme

June 11, 2012 Sales and Marketing Asia, BMS, China, India, Onglyza, diabetes

Bristol-Myers Squibb has invested $15 million into its ‘Together on Diabetes’ campaign in India and China. Together on Diabetes is …
News

Pfizer to create standalone animal health business

June 8, 2012 Sales and Marketing Ian Read, Pfizer, Zoetis, nestle, standalone

Pfizer has said it is setting up a new standalone company out of its animal health division. This means it …
News

New COO for Lonza Life Science Ingredients

June 8, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Beat In-Albon, COO, Lonza

Lonza has appointed Beat In-Albon as chief operating officer of its Life Science Ingredients sector. In-Albon, 60, becomes a member …
Appointment

Pharma calls for urgent change in German system

June 8, 2012 Sales and Marketing AMNOG, EFPIA, Germany, Trajenta, VFA

Europe’s pharma industry has called on the German government to re-think its approach to pricing, saying it is could cause …
News

Patients urged to rate GPs

June 8, 2012 Medical Communications, Sales and Marketing DH, England, GPs, Lord Howe, NHS

The government is cranking up its information strategy with the publication of new data on 8,000 GP surgeries in England. …
News

Lechleiter wants policy that spurs innovation

June 8, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Lechleiter, Obama, PhRMA, US, heathcare, lilly

Lilly’s leader is calling on governments to take the long-term view when it comes to healthcare policy. John Lechleiter who …
News

RoActemra superior to Humira as single-agent therapy

June 7, 2012 Research and Development, Sales and Marketing Humira, Orencia, RA, RoActemra, Roche. ADACTA

Roche’s RoActemra (tocilizumab) is more effective in treating rheumatoid arthritis as a single agent than market leader Humira, a new …
News

Former Teva president joins Sun Pharma

June 7, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Sun Pharma, Teva, generics, manufacturing

Sun Pharma has appointed Israel Makov as its new chairman of the board. Makov is the former president and chief …
Appointment

ABPI ‘fears for future of UK research’ ahead of pricing talks

June 7, 2012 Sales and Marketing ABPI, Drug pricing, PPRS, Stephen Whitehead, VBP

The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …
News

Shire makes two senior appointments

June 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Colpman, Judge, Shire

Shire has announced the promotion of David Colpman and Ann Judge (pictured) as two senior leaders within the firm.  Colpman, …
Appointment

Global marketing access strategy: local activation

June 6, 2012 Business Services, Medical Communications, Sales and Marketing Global marketing, MSI, market access

Pharma has historically been an industry that likes to put things in boxes, neatly organising different aspects of commercialisation into …
Feature

William Kaelin Jr elected to Lilly board

June 6, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Kaelin, lilly

Eli Lilly has elected William Kaelin Jr to its board of directors. Dr Kaelin, 54, is a Professor in the Department of …
Appointment

Herceptin successor impresses at ASCO

June 6, 2012 Research and Development, Sales and Marketing ASCO, Cancer, EMILIA, FDA, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug T-DM1 has impressed at this year’s ASCO conference in Chicago. The trial showed it …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026